Two Single-Arm, Multicenter Phase-Ii Trials Of Pd-1 Inhibitors In Patients With Pulmonary Sarcomatoid Carcinoma (Ncch1603/Ncch1703)
ANNALS OF ONCOLOGY(2021)
摘要
Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small cell lung cancer, occurring in <1% of all lung tumors. PSC is highly resistant to conventional cytotoxic chemotherapies and confers a poor prognosis. Two single-arm, multicenter phase-II trials were conducted to evaluate the efficacy and safety of PD-1 inhibitors in patients with PSC.
更多查看译文
关键词
pulmonary sarcomatoid carcinoma,inhibitors,single-arm
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要